ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

702 hedge funds and large institutions have $38.8B invested in Alexion Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 240 increasing their positions, 293 reducing their positions, and 101 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

36% less first-time investments, than exits

New positions opened: 65 | Existing positions closed: 101

73% less call options, than puts

Call options by funds: $108M | Put options by funds: $402M

Holders
702
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
77
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$108M
Puts
$402M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
601
$50K
602
$46K
603
$45K
604
$45K
605
$45K
606
$44K
607
$44K
608
$40K
609
$39K
610
$38K
611
$38K
612
$37K
613
$35K
614
$35K
615
$34K
616
$33K
617
$32K
618
$31K
619
$28K
620
$28K
621
$27K
622
$26K
623
$26K
624
$25K
625
$25K